The recent reports 1,2 of high levels of osletamivir (neuraminidase inhibitor) resistance in seasonal influenza have caused concern because the resistance was in patients who had not recently taken osletamivir 3 , and the genetic change, H274Y, was the same change that confers resistance to oseltamivir in the potential pandemic influenza sub-type, H5N1 4 .
The recent reports 1,2 of high levels of osletamivir (neuraminidase inhibitor) resistance in seasonal influenza have caused concern because the resistance was in patients who had not recently taken osletamivir 3 , and the genetic change, H274Y, was the same change that confers resistance to oseltamivir in the potential pandemic influenza sub-type, H5N1 4 .
Moreover, the resistance was specific for H1N1 and position H274Y, supporting the notion that the high levels was not linked to oseltamivir usage.
Prior studies of oseltamivir resistance in Japan 5 were linked to sub-optimal dosing and resistance was found in both current influenza A subtypes, H1N1 and H3N2, and included, but was not limited to H274Y. Prior studies also supported a fitness penalty 6, 7 for the acquisition of H274Y, which predicted that the change would be limited to patients receiving oseltamivir.
However, the appearance of H274Y in hosts not receiving oseltamivir was reported in wild birds infected with H5N1 in Astrakhan, which was followed by patients in China and Clade 2C, supporting acquisition by homologous recombination.
Phylogenetic analysis of HA is presented in Figure 2 . Figure The movement of single nucleotide polymorphisms via recombination between closely related sequences is not unexpected. Earlier analysis of swine influenza identified multiple examples of recombination involving long stretches of identity. However, multiple recombination events led to shorter regions from a given parental sequence [13] [14] [15] .
Shorter regions were identified in an analysis of human influenza 16 . Similarly, the exchanges have also been seen for deletions. A three BP deletion appended onto H5N1 clade 2.2 in Egypt was identical to the deletion appended onto a clade 7 background in China 17 . Moreover, recombination between closely related sequences, such as H1N1 sub-clades as described in this report, or between sub-clades of H5N1 described above, produces exchanges of single nucleotide polymorphisms.
The fixing of antiviral resistance follows a general mechanism for rapid viral evolution.
Recombination places a given polymorphism onto multiple genetic backgrounds. Most of the initial introductions failed to become dominant. This was seen in the United States in the first clade 2B isolates which were in Hawaii. These isolates formed a branch with other isolates from Hawaii and California, but this sub-clade did not spread beyond the initial two isolates. This mechanism has significant theoretical and practical considerations. The acquisition of polymorphisms that have a circulated previously allows for predictions based on the present and past frequency of the polymorphisms as well as likely interactions between various genomes. In the fixing of H274Y, the polymorphism appeared on multiple H1N1
sub-clades before it was fixed throughout the northern hemisphere. The fixing was associated with the acquisition of a number of additional polymorphisms on NA and HA.
The acquisition of A193T was preceded by its association with the fixing of S31N in M2
of H1N1 clade 2C 18 , and a change at the same position on H3, S193F, was associated with the fixing of S31N on H3N2 19, 20 . Thus, the appearance of A193T at the end of 2007 was a signal that it would play a role in the spread of H274Y in the following season.
The role of A193T in the emergence of H274Y may extend beyond an immunological escape mechanism. The position has been reported to be associated with a change in tissue tropism, which affects affinity and is expressed in a species specific manner 21 .
Moreover, the dominant H1N1 reported to date for this season includes an adjacent change, H196R, which also has been linked to an affinity changes in H5N1 on a In addition to the prediction of vaccine targets, the pattern of polymorphism acquisition can be used to predict the fixing of drug resistance, such as H274Y for oseltamivir, or S31N for adamantanes in H1N1 or H3N2. The emergence of the resistance has led to a more robust influenza database, most notably for HA, NA, and MP gene segments.
However, an expanded database with sequences from more locations in Asia and Africa should create more accurate predictions of emerging polymorphisms for use in predicting vaccine targets and fixing of antiviral resistance. Clade 2B*
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